Ad R Hermus
Overview
Explore the profile of Ad R Hermus including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
1076
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Kayser S, Dekkers T, Groenewoud H, van der Wilt G, Carel Bakx J, van der Wel M, et al.
J Clin Endocrinol Metab
. 2016 May;
101(7):2826-35.
PMID: 27172433
Context: For health care planning and allocation of resources, realistic estimation of the prevalence of primary aldosteronism is necessary. Reported prevalences of primary aldosteronism are highly variable, possibly due to...
12.
van Leeuwaarde R, van Nesselrooij B, Hermus A, Dekkers O, de Herder W, van der Horst-Schrivers A, et al.
J Clin Endocrinol Metab
. 2016 Jan;
101(3):1159-65.
PMID: 26751192
Objective: Identifying a germline mutation in the multiple endocrine neoplasia type 1 (MEN1) gene in an index case has consequences for a whole family. Eligible family members should be offered...
13.
Nell S, van Leeuwaarde R, Pieterman C, de Laat J, Hermus A, Dekkers O, et al.
J Clin Endocrinol Metab
. 2015 Aug;
100(10):3850-5.
PMID: 26247473
Context: An association between ABO blood type and the development of cancer, in particular, pancreatic cancer, has been reported in the literature. An association between blood type O and neuroendocrine...
14.
de Laat J, Dekkers O, Pieterman C, Kluijfhout W, Hermus A, Pereira A, et al.
J Clin Endocrinol Metab
. 2015 Jul;
100(9):3288-96.
PMID: 26126205
Context: Guidelines advise lifelong radiological followup for asymptomatic pituitary adenomas (PITs) because of the risk for growth and subsequent visual field defects. In the context of multiple endocrine neoplasia type...
15.
Lodewijk L, Bongers P, Kist J, Conemans E, de Laat J, Pieterman C, et al.
Eur J Endocrinol
. 2015 Jan;
172(4):337-42.
PMID: 25572387
Objective: Currently, little is known about the prevalence of thyroid tumors in multiple endocrine neoplasia type 1 (MEN1) patients and it is unclear whether tumorigenesis of these thyroid tumors is...
16.
van Berkel A, Rao J, Kusters B, Demir T, Visser E, Mensenkamp A, et al.
J Nucl Med
. 2014 Jun;
55(8):1253-9.
PMID: 24925884
Unlabelled: Pheochromocytomas and paragangliomas (PPGLs) can be localized by (18)F-FDG PET. The uptake is particularly high in tumors with an underlying succinate dehydrogenase (SDH) mutation. SDHx-related PPGLs are characterized by...
17.
de Laat J, Pieterman C, van den Broek M, Twisk J, Hermus A, Dekkers O, et al.
J Clin Endocrinol Metab
. 2014 Jun;
99(9):3325-33.
PMID: 24915123
Context: The natural course and survival of neuroendocrine tumors (NETs) of thymus (Th) and lung in multiple endocrine neoplasia type 1 (MEN1) patients are still unknown. Objective: Our objective was...
18.
van de Ven A, Netea-Maier R, de Vegt F, Ross H, Sweep F, Kiemeney L, et al.
Eur J Endocrinol
. 2014 May;
171(2):183-91.
PMID: 24801590
Objective: The aim of this study was to investigate the influence of age on the association between thyroid function and mortality. Design: The Nijmegen Biomedical Study is a population-based study,...
19.
Medici M, Porcu E, Pistis G, Teumer A, Brown S, Jensen R, et al.
PLoS Genet
. 2014 Mar;
10(2):e1004123.
PMID: 24586183
Autoimmune thyroid diseases (AITD) are common, affecting 2-5% of the general population. Individuals with positive thyroid peroxidase antibodies (TPOAbs) have an increased risk of autoimmune hypothyroidism (Hashimoto's thyroiditis), as well...
20.
de Laat J, Pieterman C, Weijmans M, Hermus A, Dekkers O, de Herder W, et al.
J Clin Endocrinol Metab
. 2013 Aug;
98(10):4143-51.
PMID: 23956349
Context: The assessment of tumor markers for diagnosing pancreatic neuroendocrine tumors (pNET) in multiple endocrine neoplasia type 1 (MEN1) patients is advised in the current guidelines but has never been...